Matt Carson, PhD

The final verison of this work is now published in @angew_chem! @KozlowskiMarisa @KalyanaDuggal onlinelibrary.wiley.com/doi/10.1002/an…

Congratulations to Matt (@mccarson23) on getting the 2026 John G. Miller Award for Most Outstanding Doctoral Thesis in the Department of Chemistry! @PennChemistry

@NaOHBartfield convincing me to open mine rn

AYO

So incredibly grateful for these last 5 years in the @KozlowskiMarisa lab. Couldn't have asked for a better grad school experience.

@Cbayrak6 @KozlowskiMarisa @PennChemistry thank you!

@KozlowskiMarisa @mccarson23 @PennChemistry Congrat matt

Congratulations to Dr. Matt Carson (@mccarson23) on successfully defending his thesis! @PennChemistry

@KozlowskiMarisa @PennChemistry incredible work @AntenucciPedro

Join us this Friday for Matt's (@mccarson23) PhD thesis defense at 10:15 AM in Carolyn Hoff Lynch Lecture Hall! @PennChemistry

PENNSYLVANIA IS GOING DANCING 🕺 The Quakers head to their first NCAA tourney since 2018 after beating Yale in OT 😮

@SouvikA26351772 @jacsoljoc @angew_chem @KozlowskiMarisa @KalyanaDuggal Thanks Souvik!!

@mccarson23 @jacsoljoc @angew_chem @KozlowskiMarisa @KalyanaDuggal Congrats Matt! Very nice work!

The final verison of this work is now published in @angew_chem! @KozlowskiMarisa @KalyanaDuggal onlinelibrary.wiley.com/doi/10.1002/an…

Congratulations to Matt, Alice, Kalyana and Madeline on their work out now in @angew_chem! @PennChemistry

Dotinurad: a ‘Next-Gen’ Uricosuric Looking to Crack the US Gout Market | drughunters.com/4aOXNRs Dotinurad (FYU-981) is a URAT1 inhibitor approved for gout/hyperuricemia in Japan and China (Urece®) and is now in late-stage development in the US. By blocking renal proximal-tubule uric acid reabsorption, dotinurad increases urinary urate excretion and lowers serum urate, the key biochemical driver of gout. The molecule was optimized from the historical uricosuric benzbromarone in an effort to retain urate-lowering efficacy while reducing instances of rare but serious hepatotoxicity. Building on its clinical experience overseas, Crystalys has initiated two Ph. 3 trials benchmarking dotinurad against first-line gout treatment allopurinol, with primary completion expected in late 2027. Read more on Drug Hunter: drughunters.com/4aOXNRs

THE WOMEN OF TEAM USA DOMINATED THE PODIUM 😤 They finished with more gold medals and total medals than the men for a SIXTH straight Olympics 🥇🇺🇸

It's no secret Justin Allen has been a difference-maker for @gbphoenixmbb all season long, and what happened to him two weeks ago in Pittsburgh speaks volumes to who he is as a person: "That meant everything to me, that was the coolest experience of my life." @Justin_Allen14

The sweetest little cameo in Joel's postgame interview. 🥹 | @FultonBank

TYRESE MAXEY AND-1 GAME WINNER 🔥 40 PTS 12-18 FG 8 AST (via @NBA)

@SouvikA26351772 Thanks Souvik!!

@mccarson23 So cool! Congrats Matt!

Working on a webpage for ML predictions of the reaction selectivity. Check it out! matthewccarson.shinyapps.io/phenol_pyridin…

@mccarson23 giving a talk at Pacifichem this past week in Honolulu, HI on the final project from his PhD! 🔗 Link to the ChemRxiv preprint: lnkd.in/ek9vP3xg

@RowanSci @KozlowskiMarisa @PennChemistry Appreciate it! Your tools have really helped us accelerate reaction discovery.

Glad to see our workflows being used to predict reaction outcomes! Congrats @mccarson23 @KozlowskiMarisa @PennChemistry on a great paper + exciting new reaction.